133 / 1544
Stereotactic radiotherapy for oligometastases:
a prognostic model for survival
Aim: to identify subsets of patients that benefit in terms
of overall survival
2005
–
2011: 309 patients
≤
5 mets
SBRT (n = 209) or SRS (n = 107)
Median delivered BED = 60 Gy (range: 26
–
112 Gy)
Median follow-up = 12 months (range: 1
–
84 months)
De Vin et al, Ann Oncol 2014
11
27-1-2016